| Liebold Dental | |
|
210 11th St E Bottineau ND 58318-2052 | |
| (701) 228-2200 | |
| (701) 228-2222 |
| Full Name | Liebold Dental |
|---|---|
| Speciality | Dentist |
| Location | 210 11th St E, Bottineau, North Dakota |
| Authorized Official Name and Position | David A. Liebold (DIRECTOR) |
| Authorized Official Contact | 7012282200 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Liebold Dental Po Box 369 Bottineau ND 58318-0369 Ph: (701) 228-2200 | Liebold Dental 210 11th St E Bottineau ND 58318-2052 Ph: (701) 228-2200 |
| NPI Number | 1316483050 |
|---|---|
| Provider Enumeration Date | 01/18/2017 |
| Last Update Date | 01/18/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316483050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | ND1758 (North Dakota) | Primary |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Sanofi, one of the world's leading pharmaceutical organizations, has implemented QUOSA's literature management tools to automate adverse event monitoring.
When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.
The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
› Verified 3 days ago